The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin's Lymphoma: A Meta-Analysis

Background and Purpose. The aim of this study is to determine the prognostic value of interim and final FDG-PET in major histotypes of B-cell NHL patients treated with rituximab containing-chemotherapy. Methods. We searched for articles published in English, limited to lymphoma, rituximab, and FDG-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuyuan, Lu, Jianda, Wei, Xin, Song, Shaoli, Huang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830841/
https://www.ncbi.nlm.nih.gov/pubmed/24288671
http://dx.doi.org/10.1155/2013/275805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830841/
https://www.ncbi.nlm.nih.gov/pubmed/24288671
http://dx.doi.org/10.1155/2013/275805

Ejemplares similares